MIM
ACER

Monashee Investment Management’s Acer Therapeutics Inc ACER Stock Holding History

Monashee Investment Management’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-11,364
Closed -$229K – 148
2018
Q4 		$229K Buy
+11,364
New +$262K 0.16% 69
2018
Q3 		– Hold
0
– – – 132

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Monashee Investment Management's ACER Position: Q1 2019 in Review

Monashee Investment Management sold out of Acer Therapeutics Inc (ACER) in Q1 2019, closing a stake of 11,364 shares — an estimated $229K sold.

Monashee Investment Management first reported a position in ACER in Q4 2018 and held it in 1 quarter. The position peaked at $229K in Q4 2018. 34 funds tracked by Wall St. Rank hold ACER as of Q1 2019.

  • Monashee Investment Management reported no remaining Acer Therapeutics Inc position as of Q1 2019 after selling out during the quarter.
  • Monashee Investment Management sold 11,364 Acer Therapeutics Inc shares in Q1 2019, an estimated $229K.
  • Monashee Investment Management first reported a position in Acer Therapeutics Inc in Q4 2018 and held it in 1 quarter.
  • Monashee Investment Management's Acer Therapeutics Inc position peaked at $229K in Q4 2018.
  • 34 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q1 2019.

Based on Monashee Investment Management's 13F filing for Q1 2019, filed 13 May 2019.